Literature DB >> 23524278

Type, rather than number, of mental and physical comorbidities increases the severity of symptoms in patients with irritable bowel syndrome.

Jeffrey M Lackner1, Chang-Xing Ma, Laurie Keefer, Darren M Brenner, Gregory D Gudleski, Nikhil Satchidanand, Rebecca Firth, Michael D Sitrin, Leonard Katz, Susan S Krasner, Sarah K Ballou, Bruce D Naliboff, Emeran A Mayer.   

Abstract

BACKGROUND & AIMS: Irritable bowel syndrome (IBS) has significant mental and physical comorbidities. However, little is known about the day-to-day burden these comorbidities place on quality of life (QOL), physical and mental function, distress, and symptoms of patients.
METHODS: We collected cross-sectional data from 175 patients with IBS, which was diagnosed on the basis of Rome III criteria (median age, 41 years; 78% women), who were referred to 2 specialty care clinics. Patients completed psychiatric interviews, a physical comorbidity checklist, the IBS Symptom Severity Scale, the IBS-QOL instrument, the Brief Symptom Inventory, the abdominal pain intensity scale, and the Short Form-12 Health Survey.
RESULTS: Patients with IBS reported an average of 5 comorbidities (1 mental, 4 physical). Subjects with more comorbidities reported worse QOL after adjusting for confounding variables. Multiple linear regression analyses indicated that comorbidity type was more consistently and strongly associated with illness burden indicators than disease counts. Of 10,296 possible physical-mental comorbidity pairs, 6 of the 10 most frequent dyads involved specific conditions (generalized anxiety, depression, back pain, agoraphobia, tension headache, and insomnia). These combinations were consistently associated with greater illness and symptom burdens (QOL, mental and physical function, distress, more severe symptoms of IBS, and pain).
CONCLUSIONS: Comorbidities are common among patients with IBS. They are associated with distress and reduced QOL. Specific comorbidities are associated with more severe symptoms of IBS.
Copyright © 2013 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  12-item Short Form; BSI; Brief Symptom Inventory; Chronic Disease; Comorbidity; DSM; Diagnostic and Statistical Manual of Mental Disorders; GAD; GERD; GI; GSI; HRQOL; Health-Related Quality of Life; IBS; IBS-SSS; IBSOS; Irritable Bowel Syndrome Outcome Study; Irritable Bowel Syndrome Symptom Severity Scale; LBP; MCS; MDD; MINI; MINI International Neuropsychiatric Interview; Mental Functioning; NIH; National Institutes of Health; PCS; QOL; SF-12; SF-12 Mental Component Score; SF-12 Physical Component Score; Stress; Transdiagnostic; gastroesophageal reflux disease; gastrointestinal; generalized anxiety disorder; global severity index; health-related quality of life; irritable bowel syndrome; low back pain; major depression disorder; quality of life

Mesh:

Year:  2013        PMID: 23524278      PMCID: PMC3779619          DOI: 10.1016/j.cgh.2013.03.011

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  75 in total

Review 1.  Expanding stress theory: prolonged activation and perseverative cognition.

Authors:  Jos F Brosschot; Suzanne Pieper; Julian F Thayer
Journal:  Psychoneuroendocrinology       Date:  2005-11       Impact factor: 4.905

2.  Multimorbidity in general practice: prevalence, incidence, and determinants of co-occurring chronic and recurrent diseases.

Authors:  M van den Akker; F Buntinx; J F Metsemakers; S Roos; J A Knottnerus
Journal:  J Clin Epidemiol       Date:  1998-05       Impact factor: 6.437

Review 3.  Chronic pain and fatigue syndromes: overlapping clinical and neuroendocrine features and potential pathogenic mechanisms.

Authors:  D J Clauw; G P Chrousos
Journal:  Neuroimmunomodulation       Date:  1997 May-Jun       Impact factor: 2.492

Review 4.  Evaluation of 2-week doctor visit reporting in the national health interview survey.

Authors:  W S Edwards; D M Winn; J G Collins
Journal:  Vital Health Stat 2       Date:  1996-08

5.  Costs of care for irritable bowel syndrome patients in a health maintenance organization.

Authors:  R L Levy; M Von Korff; W E Whitehead; P Stang; K Saunders; P Jhingran; V Barghout; A D Feld
Journal:  Am J Gastroenterol       Date:  2001-11       Impact factor: 10.864

6.  Comorbidity of chronic diseases: effects of disease pairs on physical and mental functioning.

Authors:  Mieke Rijken; Marion van Kerkhof; Joost Dekker; François G Schellevis
Journal:  Qual Life Res       Date:  2005-02       Impact factor: 4.147

7.  Patient-reported outcomes for irritable bowel syndrome are associated with patients' severity ratings of gastrointestinal symptoms and psychological factors.

Authors:  Jeffrey Lackner; James Jaccard; Charles Baum; Amanda Smith; Susan Krasner; Leonard Katz; Rebecca Firth; Tatayna Raby; Cathrine Powell
Journal:  Clin Gastroenterol Hepatol       Date:  2011-06-21       Impact factor: 11.382

Review 8.  Central pain mechanisms in the rheumatic diseases: future directions.

Authors:  Kristine Phillips; Daniel J Clauw
Journal:  Arthritis Rheum       Date:  2013-02

9.  Mental-physical co-morbidity and its relationship with disability: results from the World Mental Health Surveys.

Authors:  K M Scott; M Von Korff; J Alonso; M C Angermeyer; E Bromet; J Fayyad; G de Girolamo; K Demyttenaere; I Gasquet; O Gureje; J M Haro; Y He; R C Kessler; D Levinson; M E Medina Mora; M Oakley Browne; J Ormel; J Posada-Villa; M Watanabe; D Williams
Journal:  Psychol Med       Date:  2008-03-26       Impact factor: 7.723

10.  Depression and abdominal pain in IBS patients: the mediating role of catastrophizing.

Authors:  Jeffrey M Lackner; Brian M Quigley; Edward B Blanchard
Journal:  Psychosom Med       Date:  2004 May-Jun       Impact factor: 4.312

View more
  39 in total

Review 1.  Exercise influence on the microbiome-gut-brain axis.

Authors:  Alyssa Dalton; Christine Mermier; Micah Zuhl
Journal:  Gut Microbes       Date:  2019-01-31

Review 2.  Does central sensitization help explain idiopathic overactive bladder?

Authors:  W Stuart Reynolds; Roger Dmochowski; Alan Wein; Stephen Bruehl
Journal:  Nat Rev Urol       Date:  2016-06-01       Impact factor: 14.432

3.  Sleep measures predict next-day symptoms in women with irritable bowel syndrome.

Authors:  Diana Taibi Buchanan; Kevin Cain; Margaret Heitkemper; Robert Burr; Michael V Vitiello; Jasmine Zia; Monica Jarrett
Journal:  J Clin Sleep Med       Date:  2014-09-15       Impact factor: 4.062

4.  The impact of physical complaints, social environment, and psychological functioning on IBS patients' health perceptions: looking beyond GI symptom severity.

Authors:  Jeffrey M Lackner; Gregory D Gudleski; Elyse R Thakur; Travis J Stewart; Gary J Iacobucci; Brennan Mr Spiegel
Journal:  Am J Gastroenterol       Date:  2014-01-14       Impact factor: 10.864

5.  Durability and Decay of Treatment Benefit of Cognitive Behavioral Therapy for Irritable Bowel Syndrome: 12-Month Follow-Up.

Authors:  Jeffrey M Lackner; James Jaccard; Christopher D Radziwon; Rebecca S Firth; Gregory D Gudleski; Frank Hamilton; Leonard A Katz; Laurie Keefer; Susan S Krasner; Chang-Xing Ma; Michael D Sitrin; Darren M Brenner
Journal:  Am J Gastroenterol       Date:  2019-02       Impact factor: 10.864

6.  (Can't Get No) Patient Satisfaction: The Predictive Power of Demographic, GI, and Psychological Factors in IBS Patients.

Authors:  Brian M Quigley; Christopher C Sova; Darren M Brenner; Laurie A Keefer; Michael D Sitrin; Christopher D Radziwon; Susan S Krasner; Jeffrey M Lackner
Journal:  J Clin Gastroenterol       Date:  2018-08       Impact factor: 3.062

Review 7.  Irritable bowel syndrome: a microbiome-gut-brain axis disorder?

Authors:  Paul J Kennedy; John F Cryan; Timothy G Dinan; Gerard Clarke
Journal:  World J Gastroenterol       Date:  2014-10-21       Impact factor: 5.742

8.  Pilot Study of Functional Magnetic Resonance Imaging Responses to Somatic Pain Stimuli in Youth With Functional and Inflammatory Gastrointestinal Disease.

Authors:  Jeannie S Huang; Laura Terrones; Alan N Simmons; Walter Kaye; Irina Strigo
Journal:  J Pediatr Gastroenterol Nutr       Date:  2016-11       Impact factor: 2.839

9.  Medical comorbidity and distress in patients with irritable bowel syndrome: The moderating role of age.

Authors:  Elyse R Thakur; Brian M Quigley; Hashem B El-Serag; Gregory D Gudleski; Jeffrey M Lackner
Journal:  J Psychosom Res       Date:  2016-07-16       Impact factor: 3.006

Review 10.  Complementary and alternative medicines in irritable bowel syndrome: an integrative view.

Authors:  Oliver Grundmann; Saunjoo L Yoon
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.